Search results

Skip to results

Area of interest

Type

Status

Last updated

Showing 76 to 86 of 86 results for patient information leaflets

  1. Research recommendations

    made from 2011 onwards are shown. Please contact us if you need more information.

  2. Advocacy services for adults with health and social care needs (NG227)

    This guideline covers advocacy for people using health and social care services in all adult settings (including young people under 18 using adult services). It describes how to commission and deliver effective advocacy, as well as identifying who should be offered advocacy (including who is legally entitled to it). It also covers monitoring and improving advocacy services, and training and skills for advocates and practitioners.

    NICE guideline
    Published
    9 November 2022
    View recommendations

    Sections for NG227

  3. Early and locally advanced breast cancer: diagnosis and management (NG101)

    This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.

    NICE guideline
    Last updated
    14 April 2025
    View recommendations

    Sections for NG101

  4. Familial breast cancer. Patient decision aid on taking a medicine to reduce the chance of developing breast cancer for postmenopausal women at high risk

    cancer in the past. Your decision depends on several things that this information will help to explain. Different women will feel that...

  5. Head injury: assessment and early management (NG232)

    This guideline covers assessment and early management of head injury in babies, children, young people and adults. It aims to ensure that people have the right care for the severity of their head injury, including direct referral to specialist care if needed.

    NICE guideline
    Published
    18 May 2023
    View recommendations

    Sections for NG232

  6. High-throughput non-invasive prenatal testing for fetal RHD genotype (DG25)

    Evidence-based recommendations on high-throughput non-invasive prenatal testing (NIPT) for fetal RHD genotype

    Diagnostics guidance
    Published
    9 November 2016
    View recommendations

    Sections for DG25

  7. Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)

    Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection

    Evidence summary
    Published
    17 March 2015

  8. Familial breast cancer. Patient decision aid on taking a medicine to reduce the chance of developing breast cancer for postmenopausal women at moderately increased risk

    cancer in the past. Your decision depends on several things that this information will help to explain. Different women will feel that...

  9. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at moderately increased risk

    cancer in the past. Your decision depends on several things that this information will help to explain. Different women will feel that...

  10. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at high risk

    cancer in the past. Your decision depends on several things that this information will help to explain. Different women will feel that...

  11. Developing NICE guidelines: the manual (PMG20)

    This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE